HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/4/G609    most recent 00332.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Peretti, N. Articles by Levy, E. Search for Related Content PubMed PubMed Citation Articles by Peretti, N. Articles by Levy, E.

INFLAMMATION/IMMUNITY/MEDIATORS

Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients

Departments of ¹Nutrition, ²Pediatrics, and ³Pathology, CHU Ste-Justine, Université de Montréal, Montréal, Québec, Canada; and ⁴Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgium

Submitted 19 July 2005 ; accepted in final form 27 September 2005

A common feature of cystic fibrosis (CF) is the functional derangement of the exocrine pancreas, which affects output of pancreatic lipase. This condition results in severe dietary malabsorption due to the poor hydrolysis of triacylglycerol (TG) in the lumen of the small intestine. Despite the benefits of pancreatic enzyme supplements, patients with CF present with persistent intestinal fat malabsorption. The aim of the present investigation was to determine whether defects in the intracellular phase of lipid transport occur in this pathophysiology in addition to the known disturbed digestive processes. Our hypothesis was tested by incubating intestinal biopsies from six CF and six healthy subjects with radiolabeled lipid and protein precursors. Lipid esterification and secretion were markedly decreased by 22–31% and 38–42%, respectively, in CF samples, as noted by the low incorporation of [¹⁴C]palmitic acid into TGs, phospholipids, and cholesteryl esters in patients' duodenal explants and culture media compared with controls (100%). Accordingly, the output of TG-rich lipoproteins was substantially reduced (P < 0.05), and a similar trend was observed for high-density lipoproteins. Because intestinal lipoprotein assembly/secretion shows an absolute requirement for apolipoprotein (apo) B-48, radioactive labeling experiments were performed; these experiments demonstrated a significantly (P < 0.05) diminished synthesis of apoB-48 (40%) and apoA-I (30%). Given the critical role of microsomal triglyceride transfer protein in the formation of apoB-containing lipoproteins, its activity was determined and not found to be altered in CF intestinal tissue. Together, these results suggest that CF malabsorption may also be caused by defects in mucosal mechanisms leading to abnormal lipoprotein delivery into the blood circulation.

lipoproteins; fatty acids; apolipoprotein B-48; microsomal triglyceride transfer protein; cystic fibrosis transmembrane conductance regulator

This article has been cited by other articles:

				R. C. De Lisle Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G104 - G111. [Abstract] [Full Text] [PDF]